Patient-Reported Food Noise, Cravings and Appetite in Adults with Obesity Treated with Weekly Injectable GLP-1 Based Therapies: A Prospective Real-World Study

Aims: Although pivotal trials have established efficacy in weight reduction during the use of GLP-1 based therapies, daily fluctuations in food-related experiences between scheduled assessments remain to be better characterized. We therefore aimed to assess day-to-day patterns in food noise, cravings, hunger, satiety, and fullness among adults receiving weekly semaglutide or tirzepatide for weight management. Materials and Methods: This prospective, direct-to-participant, US observational study enrolled adults receiving weekly subcutaneous semaglutide or tirzepatide for weight management with

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.